原发性皮肤边缘区淋巴增殖性疾病与原发性皮肤CD4+小/中T细胞淋巴增殖性疾病的重叠特征:基因组分析揭示的诊断挑战
该研究回顾了56例CD4+TLPD和38例PCMZL病例,比较临床、形态和免疫表型特征,并对26例进行二代测序。两种疾病均呈惰性临床过程,应对保守治疗有反应,应解释为淋巴增殖性疾病而非明显淋巴瘤。
要点
- PCMZL多累及上肢(47%)和躯干(34%),CD4+TLPD多表现为头颈部孤立性病变(91%孤立,64%头颈部)。
- 重叠病例中,6例PCMZL和11例CD4+TLPD同时存在IG和TRG克隆性重排,6例CD4+TLPD有轻链限制性浆细胞。
- 二代测序显示PCMZL更易出现基因改变,最常见累及TNFAIP3和FAS(5例改变)。
核心结论
- PCMZL和CD4+TLPD存在临床、形态和免疫表型重叠,分子检测可辅助鉴别,但部分病例难以明确分类。
- 两者均为惰性淋巴增殖性疾病,应避免过度诊断为淋巴瘤。
研究设计与样本
- 回顾性队列研究,从病理档案中识别56例CD4+TLPD和38例PCMZL病例。
- 对26例(19例CD4+TLPD,7例PCMZL)有足够材料的病例进行二代测序。
主要发现
- CD4+TLPD多表现为孤立性病变(91%),位于头颈部(64%);PCMZL多位于上肢(47%)和躯干(34%)。
- PCMZL中反应性CD3+ T细胞增多,常表达PD-1;CD4+TLPD中常含丰富反应性B细胞。
- 二代测序在15个基因中检出23个变异,PCMZL更易出现改变,最常见影响TNFAIP3和FAS(5例改变)。
临床怎么用
- 对于具有重叠特征的皮肤淋巴增殖性疾病,应结合临床、形态、免疫表型和分子检测综合诊断。
- 避免将惰性淋巴增殖性疾病误诊为明显淋巴瘤,治疗以保守治疗和管理为主。
局限性
- 仅26例进行了二代测序,样本量有限。
- 回顾性研究,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary cutaneous marginal zone lymphoproliferative disorder (PCMZL) and primary cutaneous CD4 + small/medium T-cell lymphoproliferative disorder (CD4 + TLPD) are indolent lymphoproliferative disorders. However, cases with overlapping features can be challenging. We identified 56 CD4 + TLPD and 38 PCMZL cases from our pathology archives. Clinical, morphologic, and immunophenotypic features were reviewed. Polymerase chain reaction for immunoglobulin (IG) and T-cell receptor gamma (TRG) gene rearrangements were analyzed. Next-generation sequencing studies were performed on 26 cases with adequate material, 19 with CD4 + TLPD, and 7 with PCMZL. CD4 + TLPD presented mostly (91%) as solitary lesions, located in the head and neck area (64%), while PCMZL occurred mostly in the upper extremity (47%) and trunk (34%). Lesions were sometimes multiple (40%) and recurrences (67%) were more common. Cases of PCMZL had an increase in reactive CD3 + T cells, with frequent programmed cell death protein 1 expression, whereas cases of CD4 + TLPD often contained abundant reactive B cells. Twenty-five cases were identified as having overlapping features: 6 cases of PCMZL were clonal for both IG and TRG; 11 cases of CD4 + TLPD were clonal for IG and TRG and 6 cases of CD4 + TLPD had light chain-restricted plasma cells. By next-generation sequencing, 23 variants were detected in 15 genes, with PCMZL more likely to show alterations, most commonly affecting TNFAIP3 and FAS, altered in 5 cases. Both entities have an indolent clinical course with response to conservative therapy and management, and warrant interpretation as a lymphoproliferative disorder rather than overt lymphoma.
引用
- Obiorah IE, Karrs J, Brown L, et al. Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis. Am J Surg Pathol. 2022. PMID: 36598455. doi:10.1097/PAS.0000000000001984
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。